A bill to cap the cost of insulin prices at $35 per month for Americans with diabetes was approved by the U.S. House of Representatives this afternoon.
The House approved H.R. 6833, also known as the Affordable Insulin Now Act, by a vote of 232-193.
According to the bill, beginning on January 1, 2023, group health plans and health issuers offering insurance coverage cannot apply a deductible on insulin and cannot require Americans with diabetes to pay more than $35 or the amount equal to 25% of the negotiated price of the selected insulin product, whichever is lower. The bill was introduced on